European Medicines Agency changes policy on clinical trial data publicationBMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g4073 (Published 17 June 2014) Cite this as: BMJ 2014;348:g4073
- Rory Watson
The London based European Medicines Agency (EMA) is changing its data sharing policy after criticism from the European ombudsman Emily O’Reilly, Labour MEP Glenis Willmott, the AllTrials campaign, and researchers, patients, and the public.
At its management board meeting on 12 June, the agency agreed to a proposal from executive director Guido Rasi to remove the access restriction in its data sharing policy from on screen only to allow researchers to download, save, and print clinical study reports for academic and non-commercial research purposes.
In addition, the board agreed to allow the agency …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial